Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|March 15, 2005
Capecitabine: a reviewChristine M Walko, Celeste Lindley
Journal of Pharmaceutical and Biomedical Analysis|September 15, 2007
Enantioselective liquid chromatography-mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasmaRegina V Oliveira, Joelle M Onorato, Danuta Siluk, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Developments in breast cancer therapyCeleste Lindley
Pharmacogenomics|April 21, 2012
Use of CYP2D6 genotyping in practice: tamoxifen dose adjustmentChristine M Walko, Howard McLeod
Nature Clinical Practice. Oncology|January 29, 2009
Pharmacogenomic progress in individualized dosing of key drugs for cancer patientsChristine M Walko, Howard McLeod
Journal of Pharmacy Practice|August 22, 2012
Pharmacogenomic applications in oncologyChristine M Walko, Ogechi Ikediobi
The Annals of Pharmacotherapy|July 24, 2008
Ixabepilone: a new antimitotic for the treatment of metastatic breast cancerShriya Bhushan, Christine M Walko
Clinical Therapeutics|January 11, 2007
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignanciesTed Shih, Celeste Lindley
Expert Opinion on Pharmacotherapy|December 4, 2003
Aprepitant--a novel NK1-receptor antagonistLisa Patel, Celeste Lindley
Pageof 7